Termination of the framework agreement
Filed with HKEX · Stock code 1302 · · 1 page · English
Summary by 6ix AI
Lifetech Scientific Corporation has announced the termination of a framework agreement related to a proposed acquisition and the issuance of convertible bonds. The Board decided not to proceed with the transaction and has entered into an agreement to terminate the framework agreement, releasing both parties from their obligations. The announcement also specifies that certain costs and fees must be settled by the company by a specified date.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
LifeTech Scientific Corporation on 6ix
Earlier from LifeTech Scientific
- Monthly return of equity issuer on movements in securities for the month ended 31 October 2026
- VOLUNTARY ANNOUNCEMENT - IBS TM Coronary Scaffold System Obtained CE Certification under the EU MDR
- VOLUNTARY ANNOUNCEMENT - Admission of the ICS Elpis Bioresorbable Peripheral Balloon-Expandable Covered Scaffold System into Special Examination and Approval Procedure for Innovative Medical Devices
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
- VOLUNTARY ANNOUNCEMENT - Admission of the SureCham TM Aortic Arch Single-Branch Stent Graft System into Special Examination and Approval Procedure for Innovative Medical Devices
Follow LifeTech Scientific into a list and get an email when it puts out news.
Follow LifeTech Scientific